Wondering if hormone pellet therapy is right for you? Valley Vital Medicine in Fargo answers the most common questions about EvexiPEL bioidentical pellets.
Low testosterone affects energy, mood, bone, heart health, and more. Learn what optimal levels look like and how Valley Vital Medicine helps both men and women.
Hormones affect everything from mood to bone health. Learn what perimenopause and menopause actually do to your body, and what your options are.
Learn what peptides are, how Thymosin Alpha-1, BPC-157, and TB-500 work, and why sourcing matters. A plain-language guide from Valley Vital Medicine in Fargo.
Discover how procaine IV therapy may help reset an overactive nervous system, reduce anxiety, and support recovery. Now available at Valley Vital Medicine in Fargo.
GLP-1 medications are everywhere right now. Semaglutide, tirzepatide, Ozempic, Wegovy. You can't scroll through social media or walk past a medspa without seeing them advertised. And for good reason. These medications can meaningfully reduce appetite, improve blood sugar control, and produce significant weight loss results that traditional dieting often fails to achieve. But there is a conversation that is not happening nearly enough: what kind of weight are people actually losing? At Valley Vital Medicine, that question is at the center of everything we do when it comes to weight loss support. Because the number on the scale does not tell the whole story, and in many cases, it is hiding a serious problem. What Are GLP-1 Medications? GLP-1 stands for glucagon-like peptide-1, a hormone naturally released from the intestines when you eat. GLP-1 receptor agonists work by mimicking that hormone, reducing appetite, slowing gastric emptying, and improving blood sugar regulation. Semaglutide (Ozempic, Wegovy) is a single GLP-1 receptor agonist. Tirzepatide (Mounjaro, Zepbound) is a dual agent, activating both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors, which can further improve insulin sensitivity and fat metabolism. Retatrutide, still investigational and not yet FDA-approved, adds a glucagon receptor component that may also support a higher metabolic rate. Each of these medications works differently, and which one may be appropriate for a given person, if any, is a conversation worth having with a qualified provider who understands the full picture. The Hidden Problem: You May Be Losing the Wrong Weight Research published in Circulation found that semaglutide has been associated with lean mass comprising up to 40% of total weight loss in some studies. A 2024 systematic review and network meta-analysis found that across GLP-1 receptor agonists, lean mass loss can account for roughly 25% of total weight lost. A 2025 analysis found that tirzepatide was associated with greater lean body mass loss than semaglutide at every measured time point across a 12-month period. To put that in plain terms: if someone loses 100 pounds on a GLP-1 medication without taking steps to protect their muscle, a meaningful portion of that loss may come from lean tissue rather than fat. That matters enormously. Muscle is not just about appearance or athletic performance. Muscle is your metabolism. It is what keeps your body burning calories efficiently at rest. It supports insulin sensitivity, healthy aging, and your ability to function in daily life, including getting up from the floor, climbing stairs, and staying independent as you get older. Why This Gets Worse When the Medication Stops One of the most serious concerns with GLP-1 use is what happens after. Research has shown that stopping GLP-1 therapy without the appropriate lifestyle foundation often leads to weight regain. And if lean tissue was lost during the weight loss phase, that muscle does not automatically come back when the weight returns. The result can be a body composition that is worse than before treatment began, with more fat relative to muscle, a slower resting metabolic rate, and a harder road ahead for anyone who tries to lose weight again in the future. This is not an argument against GLP-1 medications. It is an argument for doing them right. What "Doing It Right" Actually Looks Like At Valley Vital Medicine, we do not believe in handing someone a prescription and sending them on their way. Here is what a comprehensive approach to GLP-1 support looks like. Resistance training. Exercise sends a signal to the body to hold onto muscle tissue. Without it, caloric restriction, whether from medication or diet, increases the likelihood that the body will draw on lean tissue for energy. Structured strength training, particularly movements that challenge the lower body such as squats, lunges, and leg presses, is one of the most important things a person can do while on a GLP-1 medication. Adequate protein intake. Protein is the raw material the body needs to maintain muscle. A general starting point is to multiply your ideal body weight in pounds by 0.8 to find a minimum daily gram target. This can be difficult to hit, particularly when appetite is suppressed, which is why being intentional about protein and, in some cases, using targeted amino acid support becomes especially important. Hormone optimization. Caloric restriction, muscle loss, and metabolic stress all affect hormones. Testosterone, thyroid, cortisol, and growth hormone are all directly connected to muscle maintenance, energy, recovery, and fat metabolism. Many people going through a weight loss journey have underlying hormonal imbalances that go unaddressed, making their results harder to achieve and harder to sustain. Evaluating and supporting hormone levels is a core part of what we do at Valley Vital Medicine. Body composition tracking. The scale only tells you how much you weigh. It does not tell you what you are made of. We use InBody composition scanning to measure muscle mass, fat mass, hydration, and visceral fat, the fat that surrounds internal organs and raises cardiovascular risk. Tracking body composition during a weight loss program, ideally every few weeks, is the only way to know whether a person is losing fat, losing muscle, or both. Thoughtful titration. Conventional GLP-1 protocols often push patients to maximum doses as quickly as possible. At Valley Vital Medicine, we take a different approach. Starting at lower doses and increasing only when needed can reduce side effects significantly and give the body more room to adapt in a way that supports rather than undermines overall health. The Goal Is Not Just to Weigh Less Weight loss and body composition optimization are not the same thing. Someone can lose significant weight and end up metabolically worse off if that loss comes at the expense of their muscle, their hormones, and their metabolic foundation. The goal we work toward with every patient is sustainable fat loss with preserved lean tissue, so that when the work is done, the body that remains is stronger, healthier, and capable of maintaining those results without being dependent on medication indefinitely. If you are currently on a GLP-1 medication, considering one, or have come off one and are concerned about where things stand, we would love to have a conversation. Our free discovery calls are a no-pressure way to learn more about what comprehensive weight loss support looks like. Call 701-532-1926 or visit www.valleyvitalmedicine.com/call to schedule your free discovery call and learn how a functional medicine approach to weight loss can help you protect your muscle, your metabolism, and your long-term health. Medical Disclaimer: The information in this article is intended for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before beginning or modifying any weight loss program or medication regimen. References: Wilding JPH, et al. Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med. 2021;384(11):989-1002. Jastreboff AM, et al. Tirzepatide once weekly for the treatment of obesity. N Engl J Med. 2022;387(3):205-216. Prado CM, et al. Muscle and GLP-1 receptor agonists: Adaptive or maladaptive response to weight loss? Circulation. 2024. Bikou A, et al. Effect of GLP-1 receptor agonists and co-agonists on body composition: Systematic review and network meta-analysis. Metabolism. 2024. Chavez AM, et al. Nutrition support whilst on GLP-1 based therapy. Curr Opin Clin Nutr Metab Care. 2025;28(4):351-357. Frontiers in Clinical Diabetes and Healthcare. GLP-1 agonists and exercise: the future of lifestyle prioritization. 2025.